ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PRPH ProPhase Labs Inc

4.64
-0.16 (-3.33%)
08 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ProPhase Labs Inc NASDAQ:PRPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.16 -3.33% 4.64 1.90 4.75 4.85 4.60 4.85 28,604 01:00:00

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

02/05/2024 1:00pm

GlobeNewswire Inc.


ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more ProPhase Labs Charts.

ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.

Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s Investor website.

REGISTER HERE: https://www.renmarkfinancial.com/events/first-quarter-2024-results-virtual-conference-call-nasdaq-prph-2024-05-09-110000

  • To ensure smooth connectivity, please access this link using the latest version of Google Chrome.

About ProPhase Labs Inc. ProPhase Labs, Inc. (NASDAQ: PRPH) is revolutionizing healthcare through innovative solutions in biopharma, genomics, diagnostics, and therapeutics. With a commitment to advancing personalized medicine and improving patient care, ProPhase Labs is at the forefront of technological advancements in the healthcare industry. For more information, visit www.ProPhaseLabs.com

ProPhase Media Relations and Institutional Investor Contact:ProPhase Labs, Inc. 267-880-1111investorrelations@prophaselabs.com

ProPhase Retail Investor Relations Contact:Renmark Financial Communications John Boidman: 514-939-3989jboidman@renmarkfinancial.com

Source: ProPhase Labs, Inc.

1 Year ProPhase Labs Chart

1 Year ProPhase Labs Chart

1 Month ProPhase Labs Chart

1 Month ProPhase Labs Chart